Quality of life with nivolumab and AVD first-line treatment of Hodgkin lymphoma in the Phase II GHSG NIVAHL trial. (PubMed, Hemasphere) - Oct 1, 2026 - No abstract available
HEOR • Journal • P2 data • Hematological Malignancies • Hodgkin Lymphoma • Lymphoma • Oncology
|
|
Andrea Kerkhoff; Bastian von Tresckow; Christian Peter Jaworek; Ina Bühnen; Julia Meissner; Karolin Behringer; Karolin Trautmann-Grill; Michael Fuchs; Paul Jan Bröckelmann; Peter Borchmann; Peter Herhaus; Teresa Halbsguth; Valdete Schaub
|